The target gene ANGPTL4 [44, 45] is of particular interest in the context of the present study, since it not only figures in lipid metabolism as a regulator of lipoprotein lipase, but also plays an apparently essential role in tumor progression [46]. The gene discussed is LPL; the disease is neoplasm.